Hims & Hers said it would stop selling its new compounded semaglutide pill after "constructive conversations with stakeholders across the industry." ...

Here are simple, high-impact financial habits that reduce stress, build stability and quietly compound into long-term wealth.

Hims & Hers (NYSE:HIMS) shares are plunging 16% in after-hours trading following coordinated moves by two federal agencies ...

Over the last few decades, anyone who is moving into a midset of retirement planning has been fixated on one thing and only ...

The S&P 500 ( ^GSPC +1.97%) is considered the single best gauge for the overall U.S. stock market. Tom Lee at Fundstrat Global Advisors thinks the benchmark index will reach 15,000 by 2030. That ...

Let's face it: building wealth long-term can be challenging. Day-to-day expenses constantly erode the dollars we have saved so diligently, especially when prices rise relentlessly while salaries ...

Novo is threatening litigation in response to the move by the telehealth company to “unlawfully mass-market” what it called ...

Personal finance expert Suze Orman has long championed Roth retirement accounts as one of the most powerful tools for building wealth. In her 2022 book The Ultimate Retirement Guide, Orman emphasized ...

Advancements in compound chemistry have made it possible for tire makers to deliver sporty rubber that also works well ...

Novo Nordisk said on Thursday it would take legal action against Hims & Hers after the online telehealth company said it will ...

Researchers say governments and financial institutions underestimating threat because they rely on models that assume climate ...

Market conditions have the average Joe and working-class in a tight grip, but how is it affecting our chances to acquire a ...